A stepwise approach to the management of metastatic midgut carcinoid tumor

Nature Reviews Clinical Oncology

Volumn 6, Issue 7, 2009, Pages 429-433

  Bhattacharyya, Sanjeev ^a   Gujral, Dorothy M ^a   Toumpanakis, Christos ^a   Dreyfus, Gilles ^b   Davidson, Brian R ^a   Davar, Joseph ^a   Caplin, Martyn E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; OCTREOTIDE; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; SYNAPTOPHYSIN; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; SOMATOSTATIN;

ABDOMINAL PAIN; ADULT; ARTICLE; CACHEXIA; CARCINOID; CASE REPORT; CENTRAL VENOUS PRESSURE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG DOSE TITRATION; DYSPNEA; ECHOCARDIOGRAPHY; FLUSHING; HEPATOMEGALY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LIVER BIOPSY; MALE; METASTASIS POTENTIAL; MIDGUT; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE STENOSIS; SYSTOLIC HEART MURMUR; WEIGHT REDUCTION; CARCINOID SYNDROME; CHEMOEMBOLIZATION; DELAYED RELEASE FORMULATION; INTESTINE TUMOR; LIVER TUMOR; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

ANTINEOPLASTIC AGENTS; CARCINOID HEART DISEASE; CARCINOID TUMOR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; DELAYED-ACTION PREPARATIONS; HUMANS; INTESTINAL NEOPLASMS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SOMATOSTATIN;

EID: 70349576710     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2009.70     Document Type: Article

References (15)

1. Modlin, I. M. et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 9, 61-72 (2008).
2. Caplin, M. E. et al. Carcinoid tumor. Lancet 352, 799-805 (1998).
3. Ramage, J. et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 54 (Suppl. 4), iv1-16 (2005).
4. Bhattacharyya, S. Davar, J., Dreyfus, G. & Caplin, M. E. Carcinoid heart disease. Circulation 116, 2860-2865 (2007).
5. Kaltsas, G. A., Besser, G. M. & Grossman, A. B. The diagnosis and medical management of advanced neuroendocrine tumours. Endocr. Rev. 25, 458-511 (2004).
6. Sarmiento, J. M. et al. Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival. J. Am. Coll. Surg. 197, 29-37 (2003).
7. Steinmüller, T. et al. Consensus guidelines for the management of patients with liver metastases from digestive (neuro endocrine tumors: Foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 87, 47-62 (2008).
8. Que, F. G., Nagorney, D. M., Batts, K. P., Linz, L. J. & Kvols, L. K. Hepatic resection for metastatic neuroendocrine carcinomas. Am. J. Surg. 169, 36-42 (1995).
9. Eriksson, B. et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology 87, 8-19 (2008).
10. Connolly, H. M. et al. Outcome of cardiac surgery for carcinoid heart disease. J. Am. Coll. Cardiol. 25, 410-416 (1995).
11. Møller, J. E. et al. Prognosis of carcinoid heart disease: An analysis of 200 cases over two decades. Circulation 112, 3320-3327 (2005).
12. Kousnetzoff, M. et al. Sur la resection partielle du foie chez l'homme et chez les animaux [French]. Rev. Chir. 17, 319-331 (1897).
13. Parks, R. W., Chrysos, E. & Diamond, T. Management of liver trauma. Br. J. Surg. 86, 1121-1135 (1999).
14. Mays, E. T. The hazards of suturing certain wounds of the liver. Surg. Gyn. Obstet. 143, 201-204 (1976).
15. Gurusamy, K. S., Kumar, Y., Sharma, D. & Davidson, B. R. Methods of vascular occlusion for elective liver resection. Cochrane Database Syst. Rev. 4, CD006409 (2007).